Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells

Three artificial proteins that bind the gadolinium ion (Gd<sup>3+</sup>) with tumour-specific ligands were de novo engineered and tested as candidate drugs for binary radiotherapy (BRT) and contrast agents for magnetic resonance imaging (MRI). Gd<sup>3+</sup>-binding modules...

Full description

Bibliographic Details
Main Authors: Natalia V. Pozdniakova, Oxana V. Ryabaya, Alevtina S. Semkina, Vsevolod A. Skribitsky, Alexei B. Shevelev
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/6/3297
_version_ 1797470808201756672
author Natalia V. Pozdniakova
Oxana V. Ryabaya
Alevtina S. Semkina
Vsevolod A. Skribitsky
Alexei B. Shevelev
author_facet Natalia V. Pozdniakova
Oxana V. Ryabaya
Alevtina S. Semkina
Vsevolod A. Skribitsky
Alexei B. Shevelev
author_sort Natalia V. Pozdniakova
collection DOAJ
description Three artificial proteins that bind the gadolinium ion (Gd<sup>3+</sup>) with tumour-specific ligands were de novo engineered and tested as candidate drugs for binary radiotherapy (BRT) and contrast agents for magnetic resonance imaging (MRI). Gd<sup>3+</sup>-binding modules were derived from calmodulin. They were joined with elastin-like polypeptide (ELP) repeats from human elastin to form the four-centre Gd<sup>3+</sup>-binding domain (4MBS-domain) that further was combined with F3 peptide (a ligand of nucleolin, a tumour marker) to form the F3-W4 block. The F3-W4 block was taken alone (E2-13W4 protein), as two repeats (E1-W8) and as three repeats (E1-W12). Each protein was supplemented with three copies of the RGD motif (a ligand of integrin αvβ3) and green fluorescent protein (GFP). In contrast to Magnevist (a Gd-containing contrast agent), the proteins exhibited three to four times higher accumulation in U87MG glioma and A375 melanoma cell lines than in normal fibroblasts. The proteins remained for >24 h in tumours induced by Ca755 adenocarcinoma in C57BL/6 mice. They exhibited stability towards blood proteases and only accumulated in the liver and kidney. The technological advantages of using the engineered proteins as a basis for developing efficient and non-toxic agents for early diagnosis of tumours by MRI as well as part of BRT were demonstrated.
first_indexed 2024-03-09T19:41:09Z
format Article
id doaj.art-2ba66034ecdd499bae20cdc96fe893e5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T19:41:09Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2ba66034ecdd499bae20cdc96fe893e52023-11-24T01:36:57ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-03-01236329710.3390/ijms23063297Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour CellsNatalia V. Pozdniakova0Oxana V. Ryabaya1Alevtina S. Semkina2Vsevolod A. Skribitsky3Alexei B. Shevelev4N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, RussiaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, RussiaDepartment of Medical Nanobiotechnologies, Pirogov Russian National Research Medical University, Ostrovityanova, 1, 117997 Moscow, RussiaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, RussiaN.I. Vavilov Institute of General Genetics RAS, Gubkina 3, GSP-1, 119991 Moscow, RussiaThree artificial proteins that bind the gadolinium ion (Gd<sup>3+</sup>) with tumour-specific ligands were de novo engineered and tested as candidate drugs for binary radiotherapy (BRT) and contrast agents for magnetic resonance imaging (MRI). Gd<sup>3+</sup>-binding modules were derived from calmodulin. They were joined with elastin-like polypeptide (ELP) repeats from human elastin to form the four-centre Gd<sup>3+</sup>-binding domain (4MBS-domain) that further was combined with F3 peptide (a ligand of nucleolin, a tumour marker) to form the F3-W4 block. The F3-W4 block was taken alone (E2-13W4 protein), as two repeats (E1-W8) and as three repeats (E1-W12). Each protein was supplemented with three copies of the RGD motif (a ligand of integrin αvβ3) and green fluorescent protein (GFP). In contrast to Magnevist (a Gd-containing contrast agent), the proteins exhibited three to four times higher accumulation in U87MG glioma and A375 melanoma cell lines than in normal fibroblasts. The proteins remained for >24 h in tumours induced by Ca755 adenocarcinoma in C57BL/6 mice. They exhibited stability towards blood proteases and only accumulated in the liver and kidney. The technological advantages of using the engineered proteins as a basis for developing efficient and non-toxic agents for early diagnosis of tumours by MRI as well as part of BRT were demonstrated.https://www.mdpi.com/1422-0067/23/6/3297recombinant protein engineeringELPbinary radiotherapygadolinium contrast agentF3 peptideRGD
spellingShingle Natalia V. Pozdniakova
Oxana V. Ryabaya
Alevtina S. Semkina
Vsevolod A. Skribitsky
Alexei B. Shevelev
Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
International Journal of Molecular Sciences
recombinant protein engineering
ELP
binary radiotherapy
gadolinium contrast agent
F3 peptide
RGD
title Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
title_full Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
title_fullStr Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
title_full_unstemmed Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
title_short Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells
title_sort using elp repeats as a scaffold for de novo construction of gadolinium binding domains within multifunctional recombinant proteins for targeted delivery of gadolinium to tumour cells
topic recombinant protein engineering
ELP
binary radiotherapy
gadolinium contrast agent
F3 peptide
RGD
url https://www.mdpi.com/1422-0067/23/6/3297
work_keys_str_mv AT nataliavpozdniakova usingelprepeatsasascaffoldfordenovoconstructionofgadoliniumbindingdomainswithinmultifunctionalrecombinantproteinsfortargeteddeliveryofgadoliniumtotumourcells
AT oxanavryabaya usingelprepeatsasascaffoldfordenovoconstructionofgadoliniumbindingdomainswithinmultifunctionalrecombinantproteinsfortargeteddeliveryofgadoliniumtotumourcells
AT alevtinassemkina usingelprepeatsasascaffoldfordenovoconstructionofgadoliniumbindingdomainswithinmultifunctionalrecombinantproteinsfortargeteddeliveryofgadoliniumtotumourcells
AT vsevolodaskribitsky usingelprepeatsasascaffoldfordenovoconstructionofgadoliniumbindingdomainswithinmultifunctionalrecombinantproteinsfortargeteddeliveryofgadoliniumtotumourcells
AT alexeibshevelev usingelprepeatsasascaffoldfordenovoconstructionofgadoliniumbindingdomainswithinmultifunctionalrecombinantproteinsfortargeteddeliveryofgadoliniumtotumourcells